New report warns of the impacts of rare kidney diseases
People living with rare kidney diseases are facing significant delays in diagnosis, inconsistent care, and long waits for new treatments,...
People living with rare kidney diseases are facing significant delays in diagnosis, inconsistent care, and long waits for new treatments,...
The U.S. Food and Drug Administration (FDA) on Friday issued a warning that Veozah (fezolinetant), a medicine used to treat...